Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
6,779 total articles
Aclarion, Inc., a healthcare technology company, has secured a U.S. patent (#12,601,803) for its AI-driven machine learning platform that analyzes magnetic resonance spectroscopy data to help physicians identify chronic low back pain sources. This strengthens their cloud-based Nociscan platform by protecting AI applications that automate biomarker …
DT Midstream, Inc. announced it will release its first quarter 2026 financial results on April 30, 2026, before the market opens. The company has scheduled a conference call to discuss the results the same morning, with live webcast access provided for investors and the public.
Kailera Therapeutics, a clinical-stage biotech company specializing in advanced obesity treatments, announced the pricing of its IPO at $16 per share, expected to raise approximately $625 million before expenses. The company plans to list its common stock on Nasdaq under the ticker KLRA on April 17, 2026. The funds raised aim to support Kailera's c…
Bilibili Inc., a leading Chinese video community platform, has published its 2025 Environmental, Social and Governance (ESG) Report. The report details the company's progress in adopting sustainable and responsible business practices, aiming to create value for users, creators, employees, partners, and the broader community. The report is available…
Manhattan Bridge Capital, Inc. reported a slight decrease in net income for Q1 2026 compared to the same period in 2025, with net income of approximately $1.27 million down 7.2% primarily due to lower revenue from reduced loan origination activity and loan receivables. Despite this, the company saw reduced interest expenses and an encouraging level…
Kaspi.kz held its Annual General Meeting on April 15, 2026, approving the 2025 audited financial statements, a dividend of 850 KZT per common share, and reappointing Deloitte LLP as external auditor. The company also approved stock option awards as part of long-term incentives for Board Members.
Radiopharm Theranostics announced the completion of patient enrollment in their U.S. Phase 2b imaging trial for RAD 101, a novel imaging agent targeting fatty acid synthase for detecting recurrent brain metastases. Interim data shows 90% concordance with MRI, with full data anticipated in June 2026. The company plans to advance RAD 101 into a Phase…
Balchem Corporation will release its first quarter 2026 financial results before the market opens on April 30, 2026, followed by a conference call hosted by its CEO and CFO to discuss the results. Balchem operates in three segments: Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products, delivering specialty ingredients globall…
Brookfield Corporation announced the pricing of C$500 million medium-term notes due 2036 and a C$250 million re-opening of its existing medium-term notes due 2055. The notes offer attractive yields and carry solid investment-grade credit ratings. Proceeds will be utilized for general corporate purposes, reflecting ongoing strategic financing activi…
MeiraGTx announced positive three-year data from its Phase 1 AQUAx study evaluating AAV-hAQP1 gene therapy for grade 2/3 late radiation-induced xerostomia. The data show sustained clinical improvements in patient-reported symptoms and increased saliva flow rates, with the therapy demonstrating a strong safety profile. This durable, one-time treatme…
Harrow announced that the FDA-approved ophthalmic drug IOPIDINE® 1% has received a permanent J-Code (J2374) by CMS, effective July 1, 2026. The J-Code enables physicians to receive reimbursement for administrating IOPIDINE 1% during in-office procedures to prevent intraocular pressure spikes, a common complication of glaucoma-related laser surgerie…
Aurora Mobile Limited (NASDAQ: JG) showcased its AI-driven customer engagement platform, EngageLab, at InnoEX Hong Kong, introducing innovative solutions to streamline omnichannel communication, reduce integration complexity, and enhance AI-powered customer support. EngageLab demonstrated intelligent fallback workflows, agile customization via deve…
Adlai Nortye Ltd., a clinical-stage biotechnology company specializing in cancer therapies, announced a $150 million private investment in public equity financing. The oversubscribed placement involved new and existing institutional investors purchasing 11.3 million ADSs at $13.25 each, matching the closing Nasdaq price. The funds aim to support th…
Metagenomi Therapeutics, Inc. (Nasdaq: MGX) announced a scientific publication highlighting MG119-28, a proprietary compact CRISPR nuclease with superior genome editing efficiency compared to previously known nucleases. The research demonstrates structural and mechanistic features that improve editing in mammalian cells, supporting the company's pi…
Eton Pharmaceuticals announced that Judith M. Matthews will become its Chief Financial Officer starting June 1, 2026, succeeding current CFO James Gruber who will transition out after a consulting period. Matthews brings over 25 years of finance leadership in pharmaceutical companies, aiming to support Eton's growth and rare disease portfolio expan…
Canadian National Railway Company (CN) announced a $500,000 donation to two Winnipeg-based organizations to support programs aimed at preventing homelessness, especially among Indigenous youth and vulnerable populations. The funding is part of CN's Railroaders for Change initiative to enhance safety and well-being in communities near its operations…
MeiraGTx Holdings plc has entered into an asset purchase agreement with Johnson & Johnson to acquire all interests in botaretigene sparoparvovec (bota-vec), a gene therapy for X-linked Retinitis Pigmentosa (XLRP). With strong Phase 3 trial data supporting clinically meaningful vision improvements in patients with no current treatment options, Meira…
Holley Performance Brands (NYSE: HLLY) announced the launch of Cataclean Diesel Exhaust System & DPF Cleaner, a diesel-specific emissions treatment designed to improve diesel engine performance and emissions system efficiency. This new product expands Cataclean's market reach into diesel vehicles, supporting Holley's broader American Performance ch…
JD.com, a leading supply chain-based technology and service provider, has filed its annual report on Form 20-F with the SEC for the fiscal year ended December 31, 2025. The company also published a substantially similar annual report in Hong Kong as required by HKEx. These reports provide audited consolidated financial statements and detail JD.com'…
Helus Pharma, a clinical stage pharmaceutical company developing novel serotonergic agonists (NSAs) for mental health conditions, announced the appointment of Dr. Ken Kramer as Senior Vice President, Medical Affairs. Dr. Kramer brings over 25 years of neuroscience and medical launch experience, including leadership roles at Bristol Myers Squibb and…
Xilio Therapeutics, a clinical-stage biotech company focused on developing masked immuno-oncology therapies, announced the appointment of Cheryl R. Blanchard, Ph.D., a seasoned leader in life sciences, to its board of directors. Dr. Blanchard’s extensive experience in biologics, small molecules, and medical devices will support Xilio's advancement …
Exodus Movement, Inc. announced expanded native support for XRP Ledger (XRPL) digital assets including XRP and Ripple's enterprise-grade stablecoin RLUSD within its Exodus wallet. The collaboration with Ripple aims to enhance user experience and utility by enabling native management and transactions of XRPL assets in a self-custodial environment, r…
Alterity Therapeutics announced that Dr. Daniel Claassen will deliver a late-breaking oral presentation highlighting promising Phase 2 clinical trial results of ATH434 demonstrating a disease-modifying signal in patients with Multiple System Atrophy (MSA) at the American Academy of Neurology Annual Meeting. The company is preparing for a pivotal Ph…
MeiraGTx Holdings plc has priced an underwritten public offering of approximately 11.1 million ordinary shares at $9.00 per share, raising gross proceeds of about $100 million. The company aims to use the net proceeds in combination with existing cash to fund operations and advance potential commercial launches of its gene therapy candidates, bota-…
Gildan Activewear Inc. announced that it will release its first quarter 2026 financial and operating results on April 30, 2026, followed by a conference call for financial analysts and investors. The company is a leading manufacturer of basic apparel with a diversified portfolio of brands and operates globally with a strong focus on ESG practices.
